Peritonitis due to Cunninghamella bertholletiae in a patient undergoing continuous ambulatory peritoneal dialysis

被引:19
作者
Pimentel, JD
Dreyer, G
Lum, GD
机构
[1] Royal Darwin Hosp, No Terr Govt Pathol Serv, Casuarina, NT 0811, Australia
[2] Royal Darwin Hosp, Dept Renal Med, Casuarina, NT 0811, Australia
关键词
D O I
10.1099/jmm.0.46202-0
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Peritoneal dialysis-associated peritonitis due to fungi of the class Zygomycetes occurs very rarely. A case of fungal continuous ambulatory peritoneal dialysis peritonitis due to Cunninghamella bertholletiae is reported in a 39-year-old Aboriginal woman with end-stage renal failure and diabetes mellitus. This isolate was found to be resistant in vitro to amphotericin B, 5-fluorocytosine, fluconazole, itraconazole, ketoconazole and voriconazole. However, this patient was successfully treated with voriconazole and removal of the Tenckhoff dialysis catheter. Zygomycoses are an emerging threat among immunocompromised patients, including those with chronic renal failure. Zygomycosis due to C. bertholletiae is frequently fatal and is often non-responsive to systemic antifungal therapy. This is believed to be the first reported case of C. bertholletiae causing peritonitis in humans and one of the minority of cases involving this organism with a successful outcome.
引用
收藏
页码:115 / 118
页数:4
相关论文
共 17 条
[1]   Fungal peritonitis complicating peritoneal dialysis during an 11-year period: Report of 46 cases [J].
Bibashi, E ;
Memmos, D ;
Kokolina, E ;
Tsakiris, D ;
Sofianou, D ;
Papadimitriou, M .
CLINICAL INFECTIOUS DISEASES, 2003, 36 (07) :927-931
[2]   In vitro susceptibilities of zygomycetes to combinations of antimicrobial agents [J].
Dannaoui, E ;
Afeltra, J ;
Meis, JFGM ;
Verweij, PE .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (08) :2708-2711
[3]   In vitro susceptibilities of zygomycetes to conventional and new antifungals [J].
Dannaoui, E ;
Meletiadis, J ;
Mouton, JW ;
Meis, JFGM ;
Verweij, PE .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2003, 51 (01) :45-52
[4]  
de Hoog G.S., 2000, ATLAS CLIN FUNGI, VSecond
[5]  
EISENBERG ES, 1986, REV INFECT DIS, V8, P309
[6]  
Gloor H, 2003, SWISS MED WKLY, V133, P619
[7]   INFECTIONS DUE TO CUNNINGHAMELLA-BERTHOLLETIAE IN PATIENTS WITH CANCER - REPORT OF 3 CASES AND REVIEW [J].
KONTOYIANIS, DP ;
VARTIVARIAN, S ;
ANAISSIE, EJ ;
SAMONIS, G ;
BODEY, GP ;
RINALDI, M .
CLINICAL INFECTIOUS DISEASES, 1994, 18 (06) :925-928
[8]   Zygomycosis in a Tertiary-Care Cancer Center in the era of Aspergillus-active antifungal therapy:: A case-control observational study of 27 recent cases [J].
Kontoyiannis, DP ;
Lionakis, MS ;
Lewis, RE ;
Chamilos, G ;
Healy, M ;
Perego, C ;
Safdar, A ;
Kantarjian, H ;
Champlin, R ;
Walsh, TJ ;
Raad, II .
JOURNAL OF INFECTIOUS DISEASES, 2005, 191 (08) :1350-1360
[9]   Survival from pulmonary infection with Cunninghamella bertholletiae:: case report and review of the literature [J].
Mazade, MA ;
Margolin, JF ;
Rossmann, SN ;
Edwards, MS .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1998, 17 (09) :835-839
[10]   Peritonitis due to Aspergillus and zygomycetes in patients undergoing peritoneal dialysis:: report of 2 cases and review of the literature [J].
Nannini, EC ;
Paphitou, NI ;
Ostrosky-Zeichner, L .
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2003, 46 (01) :49-54